IRADIMED Past Earnings Performance
Past criteria checks 5/6
IRADIMED has been growing earnings at an average annual rate of 22.1%, while the Medical Equipment industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 15% per year. IRADIMED's return on equity is 24.1%, and it has net margins of 26.2%.
Key information
22.1%
Earnings growth rate
18.5%
EPS growth rate
Medical Equipment Industry Growth | 8.9% |
Revenue growth rate | 15.0% |
Return on equity | 24.1% |
Net Margin | 26.2% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
If EPS Growth Is Important To You, IRadimed (NASDAQ:IRMD) Presents An Opportunity
Feb 23Getting In Cheap On IRadimed Corporation (NASDAQ:IRMD) Is Unlikely
Feb 07Should You Investigate IRadimed Corporation (NASDAQ:IRMD) At US$45.06?
Nov 06Calculating The Intrinsic Value Of IRadimed Corporation (NASDAQ:IRMD)
Oct 13At US$41.26, Is It Time To Put IRadimed Corporation (NASDAQ:IRMD) On Your Watch List?
Feb 05Iradimed withdraws FDA filing for new infusion pump; prelim Q3 revenue rises 13% Y/Y
Oct 10IRadimed: Record Revenue Could Translate To Share Price Appreciation
Aug 23Here's Why We Think IRadimed (NASDAQ:IRMD) Is Well Worth Watching
Aug 17iRadimed Non-GAAP EPS of $0.26 beats by $0.02, revenue of $12.7M beats by $0.06M
Jul 29IRadimed: Reduce Equity Beta With Upside Capture
Jul 18IRadimed (NASDAQ:IRMD) Might Be Having Difficulty Using Its Capital Effectively
Jul 13At US$48.60, Is IRadimed Corporation (NASDAQ:IRMD) Worth Looking At Closely?
Feb 05Here's What's Concerning About IRadimed's (NASDAQ:IRMD) Returns On Capital
Jan 12Returns On Capital At IRadimed (NASDAQ:IRMD) Paint A Concerning Picture
Jul 13iRadimed EPS beats by $0.04, beats on revenue
Apr 30iRadimed EPS misses by $0.02, beats on revenue
Feb 04If You Had Bought IRadimed (NASDAQ:IRMD) Stock Five Years Ago, You Could Pocket A 70% Gain Today
Jan 31Revenue & Expenses BreakdownBeta
How IRADIMED makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 66 | 17 | 27 | 3 |
30 Sep 23 | 63 | 16 | 26 | 3 |
30 Jun 23 | 60 | 15 | 25 | 3 |
31 Mar 23 | 56 | 14 | 25 | 3 |
31 Dec 22 | 53 | 13 | 23 | 2 |
30 Sep 22 | 50 | 13 | 23 | 2 |
30 Jun 22 | 48 | 12 | 22 | 2 |
31 Mar 22 | 45 | 10 | 21 | 2 |
31 Dec 21 | 42 | 9 | 20 | 2 |
30 Sep 21 | 38 | 6 | 17 | 2 |
30 Jun 21 | 35 | 5 | 17 | 2 |
31 Mar 21 | 32 | 1 | 19 | 2 |
31 Dec 20 | 32 | 1 | 20 | 2 |
30 Sep 20 | 34 | 4 | 23 | 2 |
30 Jun 20 | 36 | 5 | 23 | 2 |
31 Mar 20 | 39 | 10 | 20 | 1 |
31 Dec 19 | 39 | 10 | 20 | 1 |
30 Sep 19 | 36 | 8 | 18 | 1 |
30 Jun 19 | 34 | 8 | 17 | 1 |
31 Mar 19 | 32 | 7 | 16 | 1 |
31 Dec 18 | 30 | 6 | 16 | 2 |
30 Sep 18 | 29 | 5 | 15 | 1 |
30 Jun 18 | 27 | 3 | 15 | 2 |
31 Mar 18 | 25 | 2 | 15 | 2 |
31 Dec 17 | 23 | 0 | 15 | 2 |
30 Sep 17 | 22 | 1 | 14 | 2 |
30 Jun 17 | 24 | 3 | 13 | 2 |
31 Mar 17 | 29 | 5 | 14 | 2 |
31 Dec 16 | 32 | 7 | 14 | 1 |
30 Sep 16 | 35 | 8 | 15 | 1 |
30 Jun 16 | 35 | 9 | 14 | 2 |
31 Mar 16 | 33 | 8 | 13 | 2 |
31 Dec 15 | 31 | 8 | 12 | 2 |
30 Sep 15 | 26 | 5 | 11 | 2 |
30 Jun 15 | 22 | 4 | 10 | 1 |
31 Mar 15 | 19 | 3 | 9 | 1 |
31 Dec 14 | 15 | 2 | 8 | 1 |
30 Sep 14 | 15 | 2 | 7 | 1 |
30 Jun 14 | 14 | 2 | 6 | 1 |
31 Mar 14 | 12 | 2 | 5 | 1 |
31 Dec 13 | 11 | 2 | 5 | 1 |
Quality Earnings: IRMD has a high level of non-cash earnings.
Growing Profit Margin: IRMD's current net profit margins (26.2%) are higher than last year (24.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: IRMD's earnings have grown significantly by 22.1% per year over the past 5 years.
Accelerating Growth: IRMD's earnings growth over the past year (34%) exceeds its 5-year average (22.1% per year).
Earnings vs Industry: IRMD earnings growth over the past year (34%) exceeded the Medical Equipment industry 8.7%.
Return on Equity
High ROE: IRMD's Return on Equity (24.1%) is considered high.